Universal Biosensors, Inc. (ASX:UBI)
0.0140
0.00 (0.00%)
Aug 19, 2025, 4:10 PM AEST
Universal Biosensors Revenue
Universal Biosensors had revenue of 1.21M AUD in the quarter ending June 30, 2025, a decrease of -25.64%. This brings the company's revenue in the last twelve months to 5.95M, down -16.52% year-over-year. In the year 2024, Universal Biosensors had annual revenue of 6.28M, down -5.28%.
Revenue (ttm)
5.95M
Revenue Growth
-16.52%
P/S Ratio
0.70
Revenue / Employee
78.30K
Employees
76
Market Cap
4.17M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.28M | -350.10K | -5.28% |
| Dec 31, 2023 | 6.63M | 2.11M | 46.58% |
| Dec 31, 2022 | 4.52M | -1.25M | -21.68% |
| Dec 31, 2021 | 5.78M | 2.58M | 80.41% |
| Dec 31, 2020 | 3.20M | -3.69M | -53.57% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nova Eye Medical | 29.27M |
| ImpediMed | 12.72M |
| CurveBeam AI | 12.10M |
| Control Bionics | 6.14M |
| CONNEQT Health | 6.05M |
| Atomo Diagnostics | 3.79M |
| Uscom | 2.58M |
| OncoSil Medical | 1.54M |